Cited by 435Gastrointestinal motility and disordersGut microbiota and healthMicroscopic Colitis

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea‐predominant irritable bowel syndrome

Open access
WEDLAKE, L., A’HERN, R., RUSSELL, D., THOMAS, K., WALTERS, J. R. F., ANDREYEV, H. J. N.·2009·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background Recurrent, watery diarrhoea affects one‐third of patients diagnosed with irritable bowel syndrome (‘IBS‐D’). Idiopathic bile acid malabsorption (‘I‐BAM’) may be the cause. Aim To determine the prevalence of I‐BAM in patients suffering from IBS‐D. Methods A systematic search was performed of publications reporting patients presenting with IBS‐D type symptoms, who were subsequently confirmed as having I‐BAM by SeHCAT scanning. Results Eighteen relevant studies, 15 prospective, comprising 1223 patients were identified. Five studies (429 patients) indicated that 10% (CI: 7–13) patients had severe bile acid malabsorption (SeHCAT 7 day retention <5% of baseline value). 17 studies (1073 patients) indicated that 32% (CI: 29–35) patients had moderate bile acid malabsorption (SeHCAT <10%). 7 studies (618 patients) indicated that 26% (CI: 23–30) patients had mild (SeHCAT <15%) bile acid malabsorption. Pooled data from 15 studies showed a dose‐response relationship according to severity of malabsorption to treatment with a bile acid binder: response to colestyramine occurred in 96% of patients with <5% retention, 80% at <10% retention and 70% at <15% retention. Conclusions Idiopathic adult‐onset bile acid malabsorption is not rare. International guidelines for the management of irritable bowel syndrome need to be revised so that clinicians become more aware of this possibility.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2009.04081.x

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Symptoms of BAD can mimic IBS-D, with between one-in-three and one-in-four patients with suspected IBS-D having an abnormal SeHCAT retention, and response rates to a bile acid sequestrant are higher at retentions of <10% or <5%.

    “Symptoms of BAD can mimic IBS-D, with between one-in-three and one-in-four patients with suspected IBS-D having an abnormal SeHCAT retention, 133 134 and response rates to a bile acid sequestrant are higher at retentions of <10% or <5%.135”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 9

  1. Jankovic G, Milutinovic S. Spectrum of bile acid malabsorption: new entities - primary ileal villous atrophy and primary bile acid malabsorption. Romanian J Gas- troenterol 2000; 9: 37-41.
  2. Schapiro RH, Heizer WD, Goldfinger SE, Aserkoff BR. (Abstract) Gastroenterology 1970; 58: 993.
  3. Egger M, Smith GD, Schneider M. Sys- tematic reviews of observational studies in: systematic reviews in healthcare. In: Eggar M, Smith GD, Altman DG, eds. Meta-analysis in context, 2nd edn. Lon- don: BMJ Publishing Group, 2001; 12: 221-7.
  4. Ford GA, Preece JD, Davies IH, Wilkinson SP. Use of the SeHCAT test for the inves- tigation of dairrhoea. Postgrad Med J 1992; 68: 272-6.
  5. Galatola G, the Italian 75SeHCAT Multi- centre Study Group. The prevalence of bile acid malabsorption in irritable bowel syn- drome and the effect of colestyramine: an uncontrolled open multicentre study. Eur J Gastroenterol Hepatol 1992; 4: 533-7.
  6. Fernandez-Banares F, Esteve M, Salas A, et al. Bile acid malabsorption in micro- scopic colitis and in previously unex- plained functional chronic diarrhoea. Dig Dis Sci 2001; 46: 2231.
  7. Muller M, Willen R, Stotzer PO. Colonos- copy and SeHCAT for investigation of chronic diarrhoea. Digestion 2004; 69: 211-8.
  8. Fernandez-Banares F, Esteve M, Salas A, et al. Systematic evaluation of the causes of watery diarrhoea with functional char- acteristics. Am J Gastroenterol 2007; 102: 2520-8.
  9. Fellous K, Jian R, Haniche M, et al. Arti- cle in French [ 75 SeCHAT test in the assessment of bile acid malabsorption. Validation and clinical significance]. Gas- troenterol Clin Biol 1994; 18: 865-72.

Cited by

Sorted by citations

Authors
WEDLAKE, L., A’HERN, R., RUSSELL, D., THOMAS, K., WALTERS, J. R. F., & ANDREYEV, H. J. N.
Affiliations
  • Royal Marsden Hospital (GB)
  • Institute of Cancer Research (GB)
  • Imperial College London (GB)
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2009-09-03
Volume
30
Issue
7
Pages
707-717
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2000891332
Cited by
435
References
31
Citations by year
2026: 16 · 2025: 19 · 2024: 27 · 2023: 19 · 2022: 26 · 2021: 44 · 2020: 26 · 2019: 37 · 2018: 23 · 2017: 22 · 2016: 30 · 2015: 36 · 2014: 30 · 2013: 28 · 2012: 19
FWCI
2.62
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Epidemiology › Microscopic Colitis
Keywords
diarrhea-predominant irritable bowel syndrome, bile acid retention, prevalence, cholestyramine, dose-response relationship
MeSH terms
Adult, Anion Exchange Resins, Bile Acids and Salts, Cholestyramine Resin, Diarrhea, Dose-Response Relationship, Drug, Humans, Malabsorption Syndromes, Prospective Studies, Retrospective Studies, Severity of Illness Index, Prevalence, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review